Your browser doesn't support javascript.
loading
[Efficacy and safety of doxazosine in combination with finasteride in the treatment of prostatic adenoma].
Urologiia ; (6): 44-9, 2008.
Article en Ru | MEDLINE | ID: mdl-19248599
ABSTRACT
Clinical effects and safety of doxazosine + finasteride combination were studied in patients with obstructive and irritative symptoms due to prostatic adenoma (PA). Lower urinary tract symptoms according to IPSS, size of the prostatic gland, Qmax and Qmid, bladder capacity, residual urine volume, blood pressure, PSA level, sexual function, side effects were assessed before and after combined use of the drugs in 30 patients aged 58 to 83 years (mean age 70.5 years). A significant regression of both obstructive and irritative symptoms by IPSS occurred after the treatment. Quality of life has improved. Combined treatment of PA patients has improved quality of life, urination parameters, reduced volume of residual urine. Good tolerance of the treatment was observed. Combined therapy with doxazosine and finasteride can be recommended as a basic scheme of treatment for patients with risk of PA progression.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Doxazosina / Finasterida / Antagonistas Adrenérgicos alfa / Inhibidores Enzimáticos Tipo de estudio: Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: Ru Revista: Urologiia Asunto de la revista: UROLOGIA Año: 2008 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Doxazosina / Finasterida / Antagonistas Adrenérgicos alfa / Inhibidores Enzimáticos Tipo de estudio: Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: Ru Revista: Urologiia Asunto de la revista: UROLOGIA Año: 2008 Tipo del documento: Article
...